Tobramycin Solution
Product Images NDC 47335-171

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Tobramycin (NDC 47335-171). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 2

A line graph titled 'Figure 2: Absolute Change From Baseline in Log10 CFUs' showing average change of Log10 colony-forming units over 24 weeks. The x-axis represents weeks, and the y-axis shows average change of Log10 CFUs. Four data lines represent Study 1 and Study 2 for both Tobramycin and Placebo groups, indicating variations in bacterial counts during drug administration periods noted as 'on drug' at weeks 0-4, 8-12, and 16-20.*

FDA Label Image

Figure10 (Figure10)

Illustration showing a hand holding a two-prong electrical plug, positioned to be inserted into a standard electrical outlet. The image demonstrates how to connect the device's power cord to an electrical source, likely related to the use or operation of the Tobramycin respiratory inhalation solution device.*

FDA Label Image

Figure11 (Figure11)

An instructional illustration showing a close-up of hands opening a Tobramycin inhalation solution vial. The vial is labeled 'Sterile For inhalation solution only,' and an arrow indicates pulling down the bottom tab to open it.*

FDA Label Image

Figure12 (Figure12)

An instructional illustration showing a hand holding a vial of Tobramycin solution, with a drop being dispensed into a nebulizer cup designed for respiratory inhalation.*

FDA Label Image

Figure13 (Figure13)

Illustration diagram showing the assembly of a nebulizer for inhalation drug delivery. The image depicts the nebulizer cup, nebulizer outlet, stem, and nebulizer top, with an arrow indicating the direction to attach the nebulizer top to the stem. The nebulizer top is shown with a semi-circle label.*

FDA Label Image

Figure14 (Figure14)

An instructional diagram labeled Figure L showing the assembly of a nebulizer for respiratory inhalation. It depicts the mouthpiece being attached to the nebulizer outlet, which is connected to the nebulizer cup with a handle.*

FDA Label Image

Figure15 (Figure15)

Illustration showing the inspiratory valve cap being placed on or removed from a respiratory inhalation device, likely for Tobramycin inhalation solution. The diagram indicates the position of the valve cap above the device with directional arrows.*

FDA Label Image

Figure16 (Figure16)

An instructional diagram showing the setup of a respiratory inhalation device with labeled air intake and arrows indicating connection points between the device parts. The image illustrates how to assemble or connect the components for inhalation use.*

FDA Label Image

Figure17 (Figure17)

An instructional illustration labeled "Figure O" showing a hand operating a switch or button on the side of a device marked "Pulmo-Aide." The image likely depicts usage or operation of a respiratory nebulizer or similar equipment.*

FDA Label Image

Figure18 (Figure18)

Illustration of a respiratory inhalation device emitting a mist or aerosol from its mouthpiece, likely depicting usage instructions or mechanism for a tobramycin inhalation solution.*

FDA Label Image

Figure19 (Figure19)

Illustration showing a person using a respiratory inhalation device with a nose clip in place, demonstrating the correct usage method for Tobramycin inhalation solution.*

FDA Label Image

Figure3 (Figure3)

An instructional diagram labeled Figure A showing components for respiratory inhalation drug use. Illustrated parts include an air compressor, nebulizer cup, inspiratory valve cap, ampule, mouthpiece, tubing, and clean paper or cloth towels arranged on a surface.*

FDA Label Image

Figure4 (Figure4)

An instructional illustration showing two hands breaking apart individual single-dose ampules from a multi-ampule strip of Tobramycin solution for respiratory inhalation. The image demonstrates the correct way to separate the ampules by bending and snapping them off from the strip.*

FDA Label Image

Figure5 (Figure5)

An instructional illustration labeled "Figure C" showing a vial or ampule with annotations pointing to fields for batch number (B. No:) and expiration date (Exp:), highlighting the location of the expiration date on the vial.*

FDA Label Image

Figure6 (Figure6)

An instructional diagram illustrating the assembly of a nebulizer device. It shows hands placing the nebulizer top onto the nebulizer cup, with labeled parts including the mouthpiece, tubing, and inspiratory valve cap, indicating how these components fit together for respiratory inhalation use.*

FDA Label Image

Figure7 (Figure7)

An instructional diagram showing the assembly of a nebulizer for inhalation solution. It depicts hands inserting the nebulizer insert into the nebulizer cup, with labels indicating the top of the insert and parts named 'Nebulizer Insert' and 'Nebulizer Cup.'*

FDA Label Image

Figure8 (Figure8)

An instructional diagram labeled Figure F showing a nebulizer cup and a component placed on clean paper or cloth towels, illustrating the parts for respiratory inhalation solution administration.*

FDA Label Image

Figure9 (Figure9)

An instructional illustration titled Figure G showing a hand opening or accessing a device labeled 'Palmo-Aide'. The image likely depicts a step in the use or preparation of a respiratory inhalation device.*

FDA Label Image

Showbox 1

Packaging label for Tobramycin Inhalation Solution, USP 300 mg/5 mL ampules by Sun Pharmaceutical Industries, Inc. The product is a respiratory inhalation solution supplied as 56 single-dose 5 mL ampules (28-day supply) packed in pouches and cartons. The label instructs to store in the refrigerator and states that the solution contains no preservatives and is for inhalation only by nebulizer.*

FDA Label Image

Spl Tobramycin Figure

A line graph titled 'Relative Change From Baseline in FEV1% Predicted' showing average relative change on the y-axis and time in weeks on the x-axis over a 24-week period. It compares the effects of Tobramycin and placebo in two different studies, with Tobramycin groups showing a higher increase in FEV1% predicted compared to placebo groups. The timeline indicates periods labeled 'on drug.'*

FDA Label Image

Structure (Structure)

Chemical structure diagram of Tobramycin, showing its molecular arrangement including sugar rings and functional groups typical of aminoglycoside antibiotics.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.